Literature DB >> 23358394

Helicobacter pylori infection in functional dyspepsia.

Hidekazu Suzuki1, Paul Moayyedi.   

Abstract

Functional dyspepsia is the most common reason for patients to experience chronic epigastric pain or discomfort. The causes of functional dyspepsia are multifactorial but Helicobacter pylori infection is one likely candidate. Infection with this bacterial pathogen clearly results in chronic mucosal inflammation in the stomach and duodenum, which, in turn, might lead to abnormalities in gastroduodenal motility and sensitivity. Chronic gastritis might also affect a variety of endocrine functions of the stomach including the production of the gastrointestinal hormones and neurotransmitters somatostatin, gastrin and ghrelin. Although these abnormalities might generate symptoms in some patients with functional dyspepsia, the clinical evidence needs to be critically evaluated before this hypothesis can be confirmed. A Cochrane review reported that eradication of H. pylori in these patients had a small but statistically significant long-term effect on symptom relief when compared with placebo, lasting at least 12 months after 1 week of eradication therapy. The efficacy of eradication therapy was seen in all symptom subtypes of functional dyspepsia, but was more marked in Asian than Western patients. This evidence has led to alterations in most of the major guidelines throughout the world, which now recommend H. pylori eradication in patients with functional dyspepsia if they test positive for this bacterium.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23358394     DOI: 10.1038/nrgastro.2013.9

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  97 in total

1.  Eradication of Helicobacter pylori and gastrin-somatostatin link in duodenal ulcer patients.

Authors:  J W Konturek; W Bielański; S J Konturek; W Domschke
Journal:  J Physiol Pharmacol       Date:  1996-03       Impact factor: 3.011

2.  The role of Acid in functional dyspepsia.

Authors:  Edoardo Savarino; Patrizia Zentilin; Pietro Dulbecco; Alberto Malesci; Vincenzo Savarino
Journal:  Am J Gastroenterol       Date:  2011-06       Impact factor: 10.864

3.  Reduced ghrelin production induced anorexia after rat gastric ischemia and reperfusion.

Authors:  Sachiko Mogami; Hidekazu Suzuki; Seiichiro Fukuhara; Juntaro Matsuzaki; Kenji Kangawa; Toshifumi Hibi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-11-23       Impact factor: 4.052

4.  Helicobacter pylori eradication induces marked increase in H+/K+-adenosine triphosphatase expression without altering parietal cell number in human gastric mucosa.

Authors:  H Osawa; H Kita; H Ohnishi; H Hoshino; H Mutoh; Y Ishino; E Watanabe; K Satoh; K Sugano
Journal:  Gut       Date:  2005-05-04       Impact factor: 23.059

Review 5.  Systematic review and meta-analysis from Chinese literature: the association between Helicobacter pylori eradication and improvement of functional dyspepsia.

Authors:  Xi Jin; You-ming Li
Journal:  Helicobacter       Date:  2007-10       Impact factor: 5.753

Review 6.  An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews.

Authors:  Paul Moayyedi; Jon Deeks; Nicholas J Talley; Brendan Delaney; David Forman
Journal:  Am J Gastroenterol       Date:  2003-12       Impact factor: 10.864

Review 7.  Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis.

Authors:  Alexander C Ford; Brendan C Delaney; David Forman; Paul Moayyedi
Journal:  Am J Gastroenterol       Date:  2004-09       Impact factor: 10.864

8.  Influence of ghrelin on the gastric accommodation reflex and on meal-induced satiety in man.

Authors:  D Ang; H Nicolai; R Vos; K Mimidis; F Akyuz; S Kindt; P Vanden Berghe; D Sifrim; I Depoortere; T Peeters; J Tack
Journal:  Neurogastroenterol Motil       Date:  2008-01-30       Impact factor: 3.598

Review 9.  Helicobacter pylori: present status and future prospects in Japan.

Authors:  Hidekazu Suzuki; Toshifumi Hibi; Barry James Marshall
Journal:  J Gastroenterol       Date:  2007-02-16       Impact factor: 7.527

Review 10.  Functional dyspepsia: past, present, and future.

Authors:  Brecht Geeraerts; Jan Tack
Journal:  J Gastroenterol       Date:  2008-05-06       Impact factor: 6.772

View more
  56 in total

Review 1.  ACG and CAG Clinical Guideline: Management of Dyspepsia.

Authors:  Paul Moayyedi; Brian E Lacy; Christopher N Andrews; Robert A Enns; Colin W Howden; Nimish Vakil
Journal:  Am J Gastroenterol       Date:  2017-06-20       Impact factor: 10.864

2.  Functional relationship between Campylobacter concisus and the stomach ecosystem in health and disease.

Authors:  Nadeem O Kaakoush; Si Ming Man; Hazel M Mitchell
Journal:  ISME J       Date:  2013-07-04       Impact factor: 10.302

Review 3.  Microbiota: a novel regulator of pain.

Authors:  Manon Defaye; Sandie Gervason; Christophe Altier; Jean-Yves Berthon; Denis Ardid; Edith Filaire; Frédéric Antonio Carvalho
Journal:  J Neural Transm (Vienna)       Date:  2019-09-24       Impact factor: 3.575

4.  Helicobacter pylori-Associated Upper Gastrointestinal Symptoms: FD or HpD?

Authors:  Hidekazu Suzuki
Journal:  Dig Dis Sci       Date:  2017-06       Impact factor: 3.199

5.  ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.

Authors:  William D Chey; Grigorios I Leontiadis; Colin W Howden; Steven F Moss
Journal:  Am J Gastroenterol       Date:  2017-01-10       Impact factor: 10.864

6.  Pepsinogen-II 100 bp ins/del gene polymorphism and its elevated circulating levels are associated with gastric cancer, particularly with Helicobacter pylori infection and intestinal metaplasia.

Authors:  Sushil Kumar; Niraj Kumari; Rama D Mittal; Uday C Ghoshal
Journal:  Gastric Cancer       Date:  2015-10-20       Impact factor: 7.370

Review 7.  Efficacy of Rebamipide in Organic and Functional Dyspepsia: A Systematic Review and Meta-Analysis.

Authors:  Mohamed Hasif Jaafar; Sher Zaman Safi; Maw-Pin Tan; Sanjay Rampal; Sanjiv Mahadeva
Journal:  Dig Dis Sci       Date:  2017-12-01       Impact factor: 3.199

8.  RELATIONSHIP BETWEEN THE PRESENCE OF HELICOBACTER PYLORI WITH INFLAMMATORY ENDOSCOPIC CHANGES IN GASTRODUODENAL MUCOSA.

Authors:  Irma Cláudia Saboya Ribeiro; Luiz Fernandao Kubrusly; Paulo Afonso Nunes Nassif; Patrícia Fernanda Saboya Ribeiro; Rodrigo de Oliveira Veras; Aline Neppel
Journal:  Arq Bras Cir Dig       Date:  2016 Jul-Sep

Review 9.  Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology.

Authors:  Nicholas J Talley; Gerald Holtmann; Marjorie M Walker
Journal:  J Gastroenterol       Date:  2015-04-29       Impact factor: 7.527

10.  First-line eradication for Helicobacter pylori-positive gastritis by esomeprazole-based triple therapy is influenced by CYP2C19 genotype.

Authors:  Yoshimasa Saito; Hiroshi Serizawa; Yukako Kato; Masaru Nakano; Masahiko Nakamura; Hidetsugu Saito; Hidekazu Suzuki; Takanori Kanai
Journal:  World J Gastroenterol       Date:  2015-12-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.